MedWatch

Xellia signs golden contract in the US

Danish Xellia Pharmaceuticals has signed a contract with newly established US non-profit organization Civica Rx, which opens the door to 500 US hospitals.

Foto: Xellia Pharmaceuticals

Danish antibiotics firm Xellia Pharmaceuticals has signed a deal that ensures the company a short cut to 500 US hospitals.

Xellia is to produce two types of antibiotics, Vancomycin and Daptomycin, for Civica Rx, a US hospital organization founded in 2018. Xellia is Civica's first supplier partner.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier